skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer

Journal Article · · Biochemical and Biophysical Research Communications
; ; ; ;  [1];
  1. Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai (China)

Highlights: • TPX2 expression is frequently upregulated in breast carcinoma and associates with the progression of breast cancer. • TPX2 regulates proliferation and cell apoptosis in breast cancer cells. • TPX2 regulates proliferation and cell apoptosis through PI3K/AKT/P21 signaling pathway. • TPX2 interacts with P53 and MDM2 to regulate cell apoptosis. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a microtubule-associated protein required for mitosis and spindle assembly. Previous studies showed that TPX2 is overexpressed in various human cancers and promotes cancer progression. In this study, the differentially expressed genes including TPX2 were screened in GEO database for gene expression microarray of breast cancer. The TPX2 expression level was significantly increased in breast cancer cells and the breast malignant tissues compared with those controls. In vitro experiment further confirmed that knockdown of TPX2 by small hairpin RNA inhibited breast cancer cell proliferatio, migration, and induced cell apoptosis. TPX2 silencing decreased the expression of PI3K and extent of AKT phosphorylation, as well as increased expression of p53 and p21. Taken together, our findings indicate that TPX2 silencing negatively regulates the PI3K/AKT and activates p53 signaling pathway by which breast cancer cells proliferation were inhibited whereas cellulars apoptosis were accelerated, suggesting that TPX2 may be a potential target for anticancer therapy in breast cancer.

OSTI ID:
23100586
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 507, Issue 1-4; Other Information: Copyright (c) 2018 Published by Elsevier Inc.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway
Journal Article · Fri Nov 29 00:00:00 EST 2013 · Biochemical and Biophysical Research Communications · OSTI ID:23100586

Lappaconitine sulfate induces apoptosis in human colon cancer HT-29 cells and down-regulates PI3K/AKT/GSK3β signaling pathway
Journal Article · Sat Jun 01 00:00:00 EDT 2019 · Medicinal Chemistry Research (Print) · OSTI ID:23100586

CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway
Journal Article · Wed Dec 15 00:00:00 EST 2021 · Experimental Cell Research · OSTI ID:23100586